Cargando…

Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review

The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much resea...

Descripción completa

Detalles Bibliográficos
Autores principales: Górna, Ilona, Napierala, Marta, Florek, Ewa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711672/
https://www.ncbi.nlm.nih.gov/pubmed/33212878
http://dx.doi.org/10.3390/toxics8040105
_version_ 1783618198149529600
author Górna, Ilona
Napierala, Marta
Florek, Ewa
author_facet Górna, Ilona
Napierala, Marta
Florek, Ewa
author_sort Górna, Ilona
collection PubMed
description The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much research has been conducted in the field of e-cigarettes and the risk of metabolic syndrome. Furthermore, taking into account the influence of e-cigarettes vaping on the individual components of metabolic syndrome, i.e, abdominal obesity, insulin resistance, dyslipidemia and elevated arterial blood pressure, the results are also ambiguous. This article is a review and summary of existing reports on the impact of e-cigarettes on the development of metabolic syndrome as well as its individual components. A critical review for English language articles published until 30 June 2020 was made, using a PubMed (including MEDLINE), Cochrane, CINAHL Plus, and Web of Science data. The current research indicated that e-cigarettes use does not affect the development of insulin resistance, but could influence the level of glucose and pre-diabetic state development. The lipid of profile an increase in the TG level was reported, while the influence on the level of concentration of total cholesterol, LDL fraction, and HDL fraction differed. In most cases, e-cigarettes use increased the risk of developing abdominal obesity or higher arterial blood pressure. Further research is required to provide more evidence on this topic.
format Online
Article
Text
id pubmed-7711672
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-77116722020-12-04 Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review Górna, Ilona Napierala, Marta Florek, Ewa Toxics Review The metabolic syndrome is a combination of several metabolic disorders, such as cardiovascular disease, atherosclerosis, and type 2 diabetes. Lifestyle modifications, including quitting smoking, are recommended to reduce the risk of metabolic syndrome and its associated complications. Not much research has been conducted in the field of e-cigarettes and the risk of metabolic syndrome. Furthermore, taking into account the influence of e-cigarettes vaping on the individual components of metabolic syndrome, i.e, abdominal obesity, insulin resistance, dyslipidemia and elevated arterial blood pressure, the results are also ambiguous. This article is a review and summary of existing reports on the impact of e-cigarettes on the development of metabolic syndrome as well as its individual components. A critical review for English language articles published until 30 June 2020 was made, using a PubMed (including MEDLINE), Cochrane, CINAHL Plus, and Web of Science data. The current research indicated that e-cigarettes use does not affect the development of insulin resistance, but could influence the level of glucose and pre-diabetic state development. The lipid of profile an increase in the TG level was reported, while the influence on the level of concentration of total cholesterol, LDL fraction, and HDL fraction differed. In most cases, e-cigarettes use increased the risk of developing abdominal obesity or higher arterial blood pressure. Further research is required to provide more evidence on this topic. MDPI 2020-11-17 /pmc/articles/PMC7711672/ /pubmed/33212878 http://dx.doi.org/10.3390/toxics8040105 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Górna, Ilona
Napierala, Marta
Florek, Ewa
Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
title Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
title_full Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
title_fullStr Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
title_full_unstemmed Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
title_short Electronic Cigarette Use and Metabolic Syndrome Development: A Critical Review
title_sort electronic cigarette use and metabolic syndrome development: a critical review
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7711672/
https://www.ncbi.nlm.nih.gov/pubmed/33212878
http://dx.doi.org/10.3390/toxics8040105
work_keys_str_mv AT gornailona electroniccigaretteuseandmetabolicsyndromedevelopmentacriticalreview
AT napieralamarta electroniccigaretteuseandmetabolicsyndromedevelopmentacriticalreview
AT florekewa electroniccigaretteuseandmetabolicsyndromedevelopmentacriticalreview